Compare · Cortechs.ai NeuroQuant

NeuroQuant Alternatives and Cortechs.ai Pricing Compared

The short answer

NeuroQuant is brain MRI volumetrics software from Cortechs.ai in San Diego, FDA-cleared since August 2006. It measures structures like the hippocampus against an age-matched normative database. Federal buyers have placed 20 orders naming it, worth $5.9 million. The cleared alternatives are icometrix icobrain (now GE HealthCare), Quantib ND, Combinostics cNeuro, Neurophet AQUA and Neuroreader.

Search for NeuroQuant and almost everything you get is either a patient looking for an MRI center that offers it or a research paper comparing its numbers with another package. Neither helps the person who has to sign the license. That is usually the operations lead at an outpatient imaging center adding volumetrics to brain MRI, a neuroradiology group asked by referring neurologists for Alzheimer's and MS reports, or a VA or military hospital renewing an annual contract.

This page puts the parts that matter to that buyer in one place. Every brain volumetrics product with a current FDA clearance, the ownership changes that happened in the last year (GE HealthCare bought icometrix in November 2025, RadNet already owns Quantib), and the only public price record for NeuroQuant, which is 20 federal orders from 2011 to 2026. Cortechs.ai publishes no price list, so those orders are the one checkable benchmark you can bring to a quote.

One more thing worth knowing before you compare: the packages do not produce identical numbers. Published studies comparing NeuroQuant with other tools on the same patients found regional volumes that differ by package. If you switch, plan a fresh baseline for patients you follow over time.

The Reading Station

Assistant ready

Worklist

Not for diagnostic use

Structured report

Draft

Run the assistant to draft this report for review.

You review & sign

Decision support. The radiologist reviews and signs every study.

Drafted in · you review & sign Worklist re-prioritized

Decision support for qualified clinicians. Radiological.ai does not provide a diagnosis and is not a substitute for professional judgment.

See the comparison

Flag · prioritize · draft · you review and sign

Cortechs.ai sells quantitative neuroimaging: segmented brain volumes compared with a normative database, lesion counts for MS and tumor follow-up, and now PET quantification. Radiological.ai does not measure brain volumes against norms. It is an assistant across the whole read: it flags suspected findings on X-ray, CT and MRI, prioritizes the worklist and drafts the structured report. You would replace NeuroQuant with another volumetrics package. You would add us beside it.

Side by side

NeuroQuant against the other FDA-cleared brain volumetrics software

Every product below holds an FDA 510(k) for automated quantification of brain MRI. Dates are FDA decision dates, not our benchmark.

What to compare	Cortechs.ai NeuroQuant	Other cleared brain volumetrics
Who owns it	Cortechs.ai, formerly CorTechs Labs, a privately held San Diego company led by CEO Kyle Frye. It closed a Series C led by VILAS Ventures in November 2024.	icobrain: GE HealthCare since November 2025. Quantib ND: RadNet, through its DeepHealth unit. cNeuro: Combinostics, Finland. AQUA: Neurophet, South Korea. Neuroreader: Brainreader, Denmark.
First clearance	K061855, August 10, 2006, the earliest of the group by about a decade.	Neuroreader K140828 (2015), Quantib Brain K153351 (2016), icobrain K161148 (2016), cNeuro cMRI K171328 (2018), Neurophet AQUA K220437 (2023).
Recent clearances	NeuroQuant K170981 (2017) and K241098 (August 2024), OnQ Neuro K210831 (2021), NeuroQuant PET K261916 (August 12, 2026).	icobrain aria K240712 (November 2024), Quantib Brain WMH K251527 (September 2025), Neurophet AQUA AD Plus K252496 (January 2026) and AQUA K261273 (May 2026).
Clinical coverage	Dementia volumetrics, MS lesion counts and change over time, brain tumor follow-up, PET quantification.	icobrain covers MS, dementia, TBI and ARIA monitoring for anti-amyloid therapy. Quantib ND covers atrophy and white matter lesions. cNeuro adds PET and DaT modules.
How it reaches US sites	Directly, on Philips Advanced Visualization Workspace, through the Siemens Healthineers Digital Marketplace (March 2026) and into Viz.ai for MS (July 2026). Federal orders mostly go through resellers.	icobrain is being integrated with GE HealthCare MRI systems. Quantib ND comes through DeepHealth. The others sell directly or through AI marketplaces.
Published price	None. The public record is 20 federal orders, including an annual unlimited license at one VA medical center for $33,988.	We found no published list price for any of them.
Where it wins	Installed base and familiarity. Referring neurologists often ask for NeuroQuant by name, and it is the package most research comparisons use as the reference.	icobrain: ARIA grading for Leqembi and Kisunla patients and MS change detection. Quantib ND: a fit for RadNet and DeepHealth sites. cNeuro: multimodal dementia work.
Switching cost	Staying keeps your baselines comparable and your referrers' report format.	Real. Volumes differ between packages, so follow-up patients need a new baseline, and referring neurologists have to learn a new report.

FDA data is from the openFDA 510(k) database, searched by applicant on October 9, 2026. Ownership facts come from GE HealthCare SEC filings (icometrix, closed November 7, 2025) and company announcements. Federal data is from USAspending.gov.

What the public record shows

What 20 federal orders say NeuroQuant costs

Cortechs.ai publishes no price. Federal buyers have bought NeuroQuant 20 times since 2011, almost always through a reseller, and every one of those orders names the product.

Measure	Figure	What it tells a buyer
All orders naming NeuroQuant	20 orders, $5,915,807, August 2011 to September 2026	A steady federal buyer base for 15 years. The median priced order is $72,370.
Military hospitals	6 Defense orders, $4,224,195, 2011 to 2015, including $2,950,330 for seven military treatment facilities in 2015	Bought as software bundles per hospital, $249,900 each at Fort Hood and Fort Campbell in 2014, during the traumatic brain injury buildout.
VA medical centers	14 orders, $1,691,612, median $64,606	The recurring shape: an annual license or service agreement per facility.
Annual unlimited license	$33,988 a year at one VA medical center, 2018 and 2019	The clearest single-site figure on record: unlimited studies for one facility for a year.
Recent renewals	$69,300 service agreement and license, July 2025 and again September 2026; $64,606 in February 2026	Current single-site renewals run in the tens of thousands of dollars a year, not per study.

Source: USAspending.gov prime awards, award types A to D, fiscal 2008 to 2026, keyword NEUROQUANT, pulled October 9, 2026. All 20 rows read by hand; one $0 order is counted but left out of the median. A recipient search for CORTECHS mostly returns CORTECHS, INC., an unrelated software testing contractor, and was discarded except two small 2010 and 2012 VA analysis orders to CORTECHS LABS.

Side by side

Radiological.ai vs Cortechs.ai NeuroQuant, honestly

A fair look at what each does well. Both are capable tools. Here is where they differ.

What matters	Radiological.ai	Cortechs.ai NeuroQuant
What you are buying	Software that flags suspected findings across the read, prioritizes the worklist and drafts the structured report.	Segmented brain volumes and lesion measurements compared with an age-matched normative database, delivered as a report.
Studies covered	X-ray, CT and MRI, under one subscription.	Brain MRI, plus PET in the newest module.
Unit of cost	Per reading radiologist, published: $399 a month on the Practice plan or $199 a month billed annually, and $598 a month on the Group plan or $299 a month billed annually.	Unpublished. Federal orders show annual site licenses and service agreements, often bought through a reseller.
Billing for the patient	Nothing separate to bill. It shortens the work behind codes you already bill.	Category III CPT codes 0865T and 0866T since January 2024, paid payer by payer.
Who signs the report	The radiologist. The assistant never signs anything.	The radiologist, who attaches or references the volumetric report.
Best suited for	Practices that want help across the whole worklist, not one measurement.	Imaging centers and neurology practices whose referrers want quantified atrophy and lesion change.

Comparison reflects general, publicly understood positioning. Capabilities change, so check each product for the latest.

Neuroradiologist reviewing a color-coded brain MRI segmentation on reading room monitors

This page covers one quantitative neuroimaging vendor. If icobrain is the product you are weighing NeuroQuant against, icobrain alternatives after the GE HealthCare deal covers ARIA monitoring and the renewal questions for GE. For acute neuro, where the buyer is a stroke program rather than an outpatient center, the best stroke AI software for hospitals compares RapidAI and Viz.ai, and RapidAI alternatives covers Brainomix and the rest of the triage field.

If cNeuro is the incumbent, Combinostics cNeuro alternatives after the SyntheticMR deal covers its clearances, the ARIA gap and what to ask at renewal.

For a category view of what AI does on MRI and the other modalities, AI medical imaging software lays out where detection, quantification and reporting assistance fit, and the best AI radiology software roundup compares the vendors side by side.

If the question is cost across vendors, how much radiology AI costs compares per-study and subscription pricing, and the pricing page lists the per-radiologist plans.

Why groups pick Radiological.ai

One assistant across the whole read

Price it as a site license

The federal record shows annual licenses per facility, $33,988 for unlimited use at one VA center and about $69,000 for a recent service agreement. If your quote is per study, convert it at your real brain MRI volume and compare.

Ask how you will bill it

CPT 0865T and 0866T are Category III codes, so each payer decides. Ask your top three commercial payers what they pay before you count the analysis as revenue rather than a cost of keeping referrers.

Plan the baseline before you switch

Volumetric packages disagree on regional volumes. If you move from NeuroQuant to icobrain or Quantib, rerun recent baselines for patients in active follow-up, and tell referrers when the report format changes.

Separate quantification from capacity

Volumetrics answers one question about one study type. If the problem is how many studies each radiologist gets through, an assistant that orders the worklist and drafts the report addresses that, and it runs beside NeuroQuant.

Good questions

Cortechs.ai NeuroQuant vs Radiological.ai, answered

Cortechs.ai, the San Diego company formerly called CorTechs Labs, makes NeuroQuant. Its CEO is Kyle Frye, and it closed a Series C round led by VILAS Ventures in November 2024. In 2025 it bought the CT imaging intellectual property of ZepMed, and it sells NeuroQuant directly and through Philips and Siemens Healthineers channels.

NeuroQuant is FDA cleared, not approved, through the 510(k) pathway. The first clearance was K061855 on August 10, 2006, followed by K170981 in 2017 and K241098 in August 2024. NeuroQuant PET was cleared as K261916 on August 12, 2026. Cleared means substantially equivalent to an existing device, which is the normal route for imaging software.

Cortechs.ai publishes no price. The public record is 20 federal orders worth $5,915,807 from 2011 to 2026. A VA medical center paid $33,988 for an annual unlimited license in 2018 and 2019, and recent VA service agreements and licenses ran $64,606 to $69,300 a year. Commercial quotes vary by volume and channel.

Since January 1, 2024, AI quantification of brain MRI is reported with Category III CPT codes: 0866T when it is done with a diagnostic brain MRI in the same session, and 0865T when it is not. The codes are vendor-neutral, so they also apply to icobrain and Quantib, and each payer decides whether and what to pay.

The FDA-cleared alternatives are icometrix icobrain, owned by GE HealthCare since November 2025, Quantib ND from RadNet's DeepHealth unit, Combinostics cNeuro cMRI, Neurophet AQUA, Neuroreader from Brainreader, and QyScore and THINQ with smaller US footprints. FreeSurfer is free but a research tool without a clinical clearance.

Neither wins outright. icobrain is stronger if you monitor anti-amyloid patients, because icobrain aria grades ARIA and was cleared in November 2024, and it is now part of GE HealthCare. NeuroQuant has the longer clearance history and the larger referrer familiarity in the US. Both cover dementia and MS, and their volumes are not interchangeable.

Yes. Volumetrics and reading assistance do different jobs. Radiological.ai receives studies over standard DICOM, flags suspected findings for review, prioritizes the worklist and drafts the structured report into your template, while NeuroQuant keeps producing its volumetric report. The radiologist reviews and signs everything.

More comparisons

See how Radiological.ai compares

vs Aidoc

Aidoc alternative

One assistant across the whole read, not acute triage alone.

vs Rad AI

Rad AI alternative

Drafting plus flagging and triage, in one assistant.

vs DeepHealth

DeepHealth alternative

Reporting AI without buying it from a competitor.

vs Fluency for Imaging

PowerScribe vs Fluency for Imaging

The two reporting platforms most US groups actually shortlist.

vs Annalise.ai

Annalise.ai alternative

Finding flags plus triage and drafting, together.

vs Nuance PowerScribe

Nuance PowerScribe alternative

More than dictation: flagging, triage and drafting.

vs Qure.ai

Qure.ai alternative

Flags plus triage and drafting, in one assistant.

vs Viz.ai

Viz.ai alternative

Beyond acute stroke triage, across the whole read.

vs Nuance DAX

Nuance DAX alternative

Built for the read, not for the patient conversation.

vs Lunit

Lunit alternative

One assistant across the whole read, not detection on two modalities.

vs Gleamer

Gleamer alternative

One assistant across X-ray, CT and MRI, not a suite of per-exam detectors.

vs PowerScribe One

PowerScribe One vs 360

What actually changes in the cloud move, and the third option.

vs Sirona Medical

Sirona Medical alternative

Add the assistant to the PACS you already run, without replacing the stack.

vs New Lantern

New Lantern alternative

AI drafting and triage on the PACS you keep, not a new platform.

vs RapidAI

RapidAI alternative

Past the stroke pathway, across the whole reading list.

vs Dragon Medical One

Dragon Medical One pricing

Microsoft publishes no price. Here are 25 real federal contracts that do.

vs PowerScribe

PowerScribe pricing

No list price exists. Here are the only verifiable numbers that do.

vs PowerScribe

PowerScribe templates

What AutoText actually is, how to get yours out, and what survives a migration.

vs RADPAIR and PowerScribe

RadPair vs PowerScribe

Three ways to write the report, compared on what each one actually replaces.

vs Aidoc and Viz.ai

Aidoc vs Viz.ai

Three acute triage platforms, compared on what they were each built to do.

vs vRad (Virtual Radiologic)

vRad alternative

vRad publishes no rate card. 357 federal contract awards do.

vs ONRAD

ONRAD alternative

ONRAD publishes no rate card. 80 federal contract awards do.

vs Real Radiology

Real Radiology alternative

Real Radiology publishes no rate card. 41 Army and VA contract awards do.

vs Experity Teleradiology

Experity Teleradiology alternative

The urgent care reading service that started as one Scottsdale radiologist and now sits inside an EMR company.

vs Sectra PACS

Sectra PACS alternative

The PACS that keeps winning satisfaction surveys, sold as a cloud subscription with no public price.

vs Visage PACS

Visage PACS alternative

The fastest-growing enterprise viewer in US radiology, priced per transaction and disclosed deal by deal.

vs Intelerad PACS

Intelerad PACS alternative

The teleradiology favorite, now a GE HealthCare business, with a renewal conversation that just changed.

vs Exa PACS

Exa PACS alternative

Often sold alongside a Konica X-ray room, with a thin public record you should fill in before you sign.

vs GE Centricity PACS

GE Centricity PACS alternative

An aging install base, three GE PACS lines under one owner, and a recall record you should read before the renewal.

vs Agfa PACS

Agfa PACS alternative

A Best in KLAS platform, a federal record over $300 million, and an IMPAX install base being moved to the cloud.

vs McKesson PACS

McKesson PACS alternative

A Horizon Medical Imaging install base now owned by Optum, a $98 million federal record and a cloud PACS sold per study.

vs Mach7

Mach7 alternative

A Vermont-run, ASX-listed enterprise imaging vendor with a new CEO, falling revenue and a seat on the VA teleradiology PACS.

vs iCAD

iCAD ProFound AI alternative

The first FDA-cleared AI for breast tomosynthesis, now owned by RadNet, the largest operator of US outpatient imaging centers.

vs ScreenPoint Transpara

Transpara alternative

Dutch mammography AI sold in the US through Siemens Healthineers and Fujifilm units, with the strongest trial record in the category.

vs Avicenna.AI CINA

Avicenna AI alternative

CT triage for stroke, pulmonary embolism and spine fractures, usually bought inside a scanner or platform vendor's bundle.

vs VIDIStar

VIDIStar alternative

A Greenville cardiology PACS bought by Hitachi in 2018, inherited by Fujifilm in 2021 and sold today as Synapse Select.

vs Subtle Medical

Subtle Medical alternative

Two vendor-neutral MRI acceleration products, four scanner makers with their own, and the FDA and federal purchase records behind each.

See every radiology use case

From the blog: what the PowerScribe 360 end of life means for radiology groups, how much radiology AI costs, and the full comparison of the best AI radiology software in 2026.

See how Radiological.ai reads alongside your group

One assistant that flags suspected findings, prioritizes the worklist, and drafts the structured report on X-ray, CT and MRI. You review and sign every study.

See pricing

Decision support for qualified clinicians. Radiological.ai does not provide a diagnosis and is not a substitute for professional medical judgment.